Management Team




Management Team




Ebrahim S. Delpassand, MD


Founder & Chairman of the Board/ CEO of RadioMedix (2006)



• Board certified nuclear medicine physician 
• Former Deputy Chair and Chief of Clinical Nuclear Medicine MD. Anderson Cancer Center 
• Founder & Chariman of Excel Diagnostics & Nuclear Oncology Center (2003)
• PI/Sponsor of current five INDs 
• Adjunct professor, Department of Radiation Oncology, UT and Nuclear Medicine at BCM in     
  Houston. 
 • Co-Founder of Infinity Care (home healthcare company) and Infinity Infusion Care. 
• Executed exit strategy for acquisition of Infinity Infusion Care by Curative Healthcare in 2002.   




Izabela Tworowsska, Ph.D, MS.Pharm

Chief Scientific Officer

Co-Founder & Board Member


  • M.S.Pharm (Clinical), Medical University, Poland
  •  Ph.D. (Chemistry), Centre of Molecular and Macromolecular Studies, Polish Academy of Science 
  •  J.W. Goethe Frankfurt University, Germany 
  •  William Rice Fellowship (Biochemistry), Rice University (Houston) 


• +25 years experience in the clinical pharmacy and chemistry 
• +13 years experience in oncology research 
• International awards: IUPAC and Sigma Aldrich Award 
• Expertise: CMC and pre-clinical evaluation of radiotheranostics drugs ( 4 INDs ) 
• Principal Investigator: 5 SBIR Phase I/II awards 
 • Co-author of +30 peer-review papers 
• Member NIH/NCI study section and Leader AlphaMedix project 


Ayda Delpassand, MSRS, MSGM  


Director of Quality Assuranceand Regulatory Affairs




  • MS (Regulatory Science) USC Los Angeles 
  • MS (Global Medicine), USC Los Angeles 
  • BS (Biology) SDSU San Diego


• Strategic and regulatory support of INDs and DMF 
• Strategic planning for CMC, Non-Clinical, Clinical, Pharmacology, Drug Safety, 
  Clinical Operations, Data Management, Biostatistics and Medical Writing to 
  support FDA submissions 
• Experienced in Regulatory Operations to ensure quality of submissions meet FDA standard 


Ali A. Abbasi, MD, PharmD 


President Spica 




  • Pharm.D. School of Pharmacy, Winchester, VA 
  • MBA, Shenandoah University, Winchester, VA 
  • MD VCW University School of Medicine, Richmond,VA 


   • Strategic and operational support of Spica Facility 
   • Support of Ge68/Ga68 generators production 
   • Experienced in cyclotron operation and management 
     (IBA Molecular North America, Sterling, VA) 
   • Supervision of submission of ANADs, DMF ( Zr89, Ga68) 


David Ranganathan,PhD 


Director for CMC - Regulatory Affairs



  • M.Sc. (Chemistry) University of Madras (India) 
  • Ph.D. University of Camerino (Italy) 
  •  Postdoctoral fellowship Washington University School of Medicine                                    


• Extensive experience in translational oncology research, managing CMOs/CROs 
  and clinical drug development. 
• Authored CMC sections and managed regulatory support for 8 INDs and 1 NDA. 
• Managing a radiopharmaceutical manufacturing facility and also led multiple tech 
  transfer programs 
• Co-author scientific articles for peer-reviewed journals 


Alphard Orot, M.S 


Quality Assurance Manager  



• +24 years experience in Quality management in the pharmaceutical 
  and biotech industry. 
• Strong background in radiochemistry, organic and analytical chemistry 
• Expertise in Internal Auditing, Method Validations and CMC preparation 
• Excellent working knowledge with different Quality Systems and FDA Guidance 
  (i.e. ISO 9001, ISO 14001, 21 CFR 210-212) 
• Familiar with aseptic manipulations, sterility testing and microbial examination 
  following USP<71>, <51>, <61> and <62>;